We manufacture Bulk Active Pharmaceutical Ingredients (API) in full compliance with USA, European Union, Korean, Japanese and Bahamian Regulatory Authorities who regularly inspect the site.
The original site developed by Syntex Pharmaceuticals is located in Freeport, Grand Bahama on 70 acres of land in the city’s industrial area.
Since 2003 we have manufactured API of a leading antiretroviral for the fight against HIV-AIDS led by Gilead Sciences, building a proven track-record of quality and excellence in cGMP manufacturing.
In furtherance of this legacy, we are building a brand new state-of-the-art multi-purpose pharmaceutical fine chemical manufacturing facility for the production of both active ingredients and intermediates, supporting Gilead’s new pipeline while accommodating new products.
Beyond the production of API and intermediates, our expertise also includes:
• Analytical Validation
• Process Validation
• Commercial Scale-up from kilo lab to full-scale manufacturing
• Technical Transfer
• Project Management